Evommune, Inc.
Ownership
Ownership Structure
Who owns Evommune, Inc. (EVMN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 54.8% of the shares are freely tradable; institutional investors hold 110.8%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| EQT Fund Management S.à r.l. | 14.57 | 5,288,313 | +7.3 | 06/30/2026 |
| RA Capital Management, LLC | 9.63 | 3,494,638 | +1.0 | 03/31/2026 |
| Pivotal bioVenture Partners Investment Advisor LLC | 5.31 | 1,926,943 | +0.0 | 06/30/2026 |
| RTW INVESTMENTS, LLC | 4.14 | 1,502,235 | +17.0 | 03/31/2026 |
| JPMorgan Chase & Co | 4.02 | 1,459,420 | +11.5 | 03/31/2026 |
| Nan Fung Group Holdings Ltd | 3.97 | 1,441,032 | +0.0 | 06/30/2026 |
| Andera Partners | 3.84 | 1,391,990 | -26.6 | 06/30/2026 |
| SymBiosis Capital Partners, LLC | 3.53 | 1,280,778 | +0.0 | 03/31/2026 |
| Eventide Asset Management, LLC | 3.33 | 1,209,129 | +0.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Eventide Healthcare & Life Sciences I | 3.33 | 1,209,129 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Kirsch Arthur S | Director | 10,000 | 94,000 $ | Jul 7, 2026 | indirect |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 7, 2026 | Kirsch Arthur S | Director | Buy | 10,000 | 13.30 | 133,000 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.